Dr. Tamila Kindwall-Keller, MD

Case Western Reserve UniversityCleveland, Ohio - 44106 |
- CLINICAL TRIALS 1
- CONDITIONS12
- INTERVENTIONS1
- SINCE2007

Efficacy and Safety Study of StemEx to Treat Subjects With High Risk Hematologic Malignancies Following Myeloablative Therapy
October 2007 - December 2013
Lymphoma
Lymphoma, Non-Hodgkin
Leukemia
Leukemia, Lymphoid
Neoplasms
Leukemia, Myeloid, Acute
Leukemia, Myeloid
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Myelodysplastic Syndromes
Preleukemia
Hodgkin Disease
Hematologic Neoplasms
Stemex®



